TNFSF10 and pancreatic neoplasm: Decoy receptors for TRAIL have shown to play a role in the pathogenesis of tumors as revealed by reports published previously by our and other laboratories [9], [15], [16], but presently no information on the prognostic significance of decoy receptors for TRAIL in pancreatic cancer is available.